Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review

Fig. 2

Non-discriminating reactive NAT yields in the blood service centers. The scale at the left indicates NAT yields (per million) in the TMA method, the donations were non-discriminating reactive (□); the scale at the right indicates the LOD (IU/mL) of different reagents in the TMA method in ID-NAT assays () and HBV discriminatory assay ()

Back to article page